Spinal pharmacology of tactile allodynia in diabetic rats

British Journal of Pharmacology

Volumn 122, Issue 7, 1997, Pages 1478-1482

  Calcutt, Nigel A ^a,c   Chaplan, Sandra R ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b University of California   (United States)

^c VA SAN DIEGO HEALTHCARE SYSTEM   (United States)

Author keywords

Allodynia; Diabetes; Diabetic neuropathy; Glutamate receptor; Pain; Spinal cord

Indexed keywords

2 AMINO 5 PHOSPHONOVALERIC ACID; 6 NITRO 7 SULFAMOYLBENZO[F]QUINOXALINE 2,3 DIONE; CALCIUM CHANNEL BLOCKING AGENT; DEXMEDETOMIDINE; DILTIAZEM; GLUTAMATE RECEPTOR; KETOROLAC; MORPHINE; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; PROSTAGLANDIN;

ALLODYNIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CATHETER; CONTROLLED STUDY; DIABETIC NEUROPATHY; LUMBAR SPINE; NOCICEPTION; NONHUMAN; PRIORITY JOURNAL; RAT; STREPTOZOCIN DIABETES;

EID: 0030733297     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0701538     Document Type: Article

References (42)

1. AHLGREN, S.C., WANG, J.F. & LEVINE, J.D. (1997). C-fiber mechanical stimulus-response functions are different in inflammatory versus neuropathic hyperalgesia in the rat. Neuroscience, 76, 285-290.
2. AHLGREN, S.C., WHITE, D.M. & LEVINE, J.D. (1992). Increased responsiveness of sensory neurons in the saphenous nerve of the streptozotocin-diabetic rat. J. Neurophysiol., 68, 2077-2085.
3. ANWYL, R. (1991). Modulation of vertebrate neuronal calcium channels by transmitters. Brain Res. Rev., 16, 265-281.
4. BACH, F.W., JENSEN, T.S., KASTRUP, J., STIGSBY, B. & DEJGÅRD, A. (1990). The effect of intravenous lidocaine on nociceptive processing in diabetic neuropathy. Pain, 40, 29-34.
5. BENBOW, S.J., CHAN, A.W., BOWSHER, D., MACFARLANE, I.A. & WILLIAMS, G. (1994). A prospective study of painful symptoms, small-fibre function and peripheral vascular disease in chronic painful diabetic neuropathy. Diabet. Med., 11, 17-21.
6. CALCUTT, N.A., JORGE, M.C., YAKSH, T.L. & CHAPLAN, S.R. (1996). Tactile allodynia and formalin hyperalgesia in streptozotocin-diabetic rats: effects of insulin, aldose reductase inhibition, and lidocaine. Pain, 68, 293-299.
7. CALCUTT, N.A., LI, L., YAKSH, T.L. & MALMBERG, A.B. (1995). Different effects of two aldose reductase inhibitors on nociception and prostaglandin E. Eur. J. Pharmacol., 285, 189-197.
8. CALCUTT, N.A., MALMBERG, A.B., YAMAMOTO, T. & YAKSH, T.L. (1994). Tolrestat treatment prevents modification of the formalin test model of prolonged pain in hyperglycemic rats. Pain, 58, 413-420.
9. CALCUTT, N.A., TOMLINSON, D.R., WILLARS, G.B. & KEEN, P. (1990). Axonal transport of substance P-like immunoreactivity in ganglioside-treated diabetic rats. J. Neurol. Sci., 96, 283-291.
10. CAPSAICIN-STUDY-GROUP (1992). Effect of treatment with capsaicin on daily activities of patients with painful diabetic neuropathy. Diabetes Care, 15, 159-65.
11. CHANG, W.P., DIMITRIADIS, E., ALLEN, T., DUNLOP, M.E., COOPER, M. & LARKINS, R.G. (1991). The effect of aldose reductase inhibitors on glomerular prostaglandin production and urinary albumin excretion in experimental diabetes mellitus. Diabetologia, 34, 225-229.
12. CHAPLAN, S.R., BACH, F.W., POGREL, J.W., CHUNG, J.M. & YAKSH, T.L. (1994a). Quantitative assessment of allodynia in the rat paw. J. Neurosci. Methods, 53, 55-63.
13. CHAPLAN, S.R., BACH, F.W., SHAFER, S.L. & YAKSH, T.L. (1995). Prolonged alleviation of tactile allodynia by intravenous lidocaine in neuropathic rats. Anesthesiology, 83, 775-785.
14. CHAPLAN, S.R., MALMBERG, A.B. & YAKSH, T.L. (1997). Efficacy of spinal NMDA receptor antagonism in formalin hyperalgesia and nerve injury evoked allodynia in the rat. J. Pharmacol. Exp. Ther., 280, 829-838.
15. CHAPLAN, S.R., POGREL, J.W. & YAKSH, T.L. (1994b). Role of voltage-dependent calcium channel subtypes in experimental tactile allodynia. J. Pharmacol. Exp. Ther., 269, 1117-1123.
16. COURTEIX, C., ESCHALIER, A. & LAVARENNE, J. (1993). Streptozocin-induced diabetic rats: behavioural evidence for a model of chronic pain. Pain, 53, 81-88.
17. DEJGÅRD, A., PETERSEN, P. & KASTRUP, J. (1988). Mexiletine for treatment of chronic painful diabetic neuropathy. Lancet, 1, 9-11.
18. DICKENSON, A.H. & SULLIVAN, A.F. (1987). Evidence for involvement of N-methylaspartate receptors in 'wind-up' of class 2 neurones in the dorsal horn of the rat. Brain Res., 424, 402-406.
19. DIEMEL, L.T., STEVENS, E.J., WILLARS, G.B. & TOMLINSON, D.R. (1992). Depletion of substance P and calcitonin gene-related peptide in sciatic nerve of rats with experimental diabetes; effects of insulin and aldose reductase inhibition. Neurosci. Lett., 137, 253-256.
20. DIXON, W.J. (1980). Efficient analysis of experimental observations. Ann. Rev. Pharmacol. Toxicol., 20, 441-462.
21. GO, V.L. & YAKSH, T.L. (1987). Release of substance P from the cat spinal cord. J. Physiol., 391, 141-167.
22. GRAHAM, M.E. & BURGOYNE, R.D. (1995). Effects of calcium channel antagonists on calcium entry and glutamate release from cultured rat cerebellar granule cells. J. Neurochem., 65, 2517-2524.
23. KASTRUP, J., ANGELO, H.R., PETERSEN, P., DEJGÅRD, A. & HILSTED, J. (1986). Treatment of chronic painful diabetic neuropathy with intravenous lidocaine infusion. Br. Med. J., 292, 173.
24. KASTRUP, J., PETERSEN, P, DEJGÅRD, A., ANGELO, H.R. & HILSTED, J. (1987). Intravenous lidocaine infusion - a new treatment of chronic painful diabetic neuropathy? Pain, 28, 69-75.
25. KIM, S.H. & CHUNG, J.M. (1992). An experimental model for peripheral neuropathy produced by segmental spinal nerve ligation in the rat. Pain, 50, 355-363.
26. KOSTYUK, E., PRONCHUK, N. & SHMIGOL, A. (1995). Calcium signal prolongation in sensory neurones of mice with experimental diabetes. NeuroReport, 6, 1010-1012.
27. LEE, Y.W., CHAPLAN, S.R. & YAKSH, T.L. (1995). Systemic and supraspinal, but not spinal, opiates suppress allodynia in a rat neuropathic pain model. Neurosci. Lett., 186, 1-4.
28. LEE, Y.W. & YAKSH, T.L. (1996). Pharmacology of the spinal adenosine receptor which mediates the antiallodynic action of intrathecal adenosine agonists. J. Pharmacol. Exp. Ther., 277, 1642-1648.
29. LIU, H., WANG, H., SHENG, M., JAN, L.Y., JAN, Y.N. & BASBAUM, A.I. (1994). Evidence for presynaptic N-methyl-D-aspartate autoreceptors in the spinal cord dorsal horn. Proc. Natl. Acad. Sci. U.S.A., 91, 8383-8387.
30. MALMBERG, A.B. & YAKSH, T.L. (1992). Antinociceptive actions of spinal nonsteroidal anti-inflammatory agents on the formalin test in the rat. J. Pharmacol. Exp. Ther., 263, 136-146.
31. MALMBERG, A.B. & YAKSH, T.L. (1993). Spinal nitric oxide synthesis inhibition blocks NMDA-induced thermal hyperalgesia and produces antinociception in the formalin test in rats. Pain, 54, 291-300.
32. MALMBERG, A.B. & YAKSH, T.L. (1995). Cyclo-oxygenase inhibition and the spinal release of prostaglandin E2 and amino acids evoked by paw formalin injection: a microdialysis study in unanesthetized rats. J. Neurosci., 15, 2768-2776.
33. MALMBERG, A.B., YAKSH, T.L. & CALCUTT, N.A. (1993). Antinociceptive effects of the GM1 ganglioside derivative AGF 44 on the formalin test in normal and streptozotocin-diabetic rats. Neurosci. Lett., 161, 45-48.
34. MAO, J., PRICE, D.D., HAYES, R.L., LU, J., MAYER, D.J. & FRENK, H. (1993). Intrathecal treatment with dextrorphan or ketamine potently reduces pain-related behaviors in rat model of peripheral mononeuropathy. Brain Res., 605, 164-168.
35. PFEIFER, MA., ROSS, D.R., SCHRAGE, J.P., GELBER, D.A., SCHUMER, M.P., CRAIN, G.M., MARKWELL, S.J. & JUNG, S. (1993). A highly successful and novel model for treatment of chronic painful diabetic peripheral neuropathy. Diabetes Care, 16, 1103-1115.
36. ROBINSON, J.P., WILLARS, G.B., TOMLINSON, D.R. & KEEN, P. (1987). Axonal transport and tissue contents of substance P in rats with long-term streptozotocin-diabetes. Effects of the aldose reductase inhibitor 'statil'. Brain Res., 426, 339-348.
37. TAKIZAWA, S., MATSUSHIMA, K., FUJITA, H., NANRI, K., OGAWA, S. & SHINOHARA, Y. (1995). A selective N-type calcium channel antagonist reduces extracellular glutamate release and infarct volume in focal cerebral ischemia. J. Cereb. Blood Flow Metab., 15, 611-618.
38. TAMURA, E. & PARRY, G.J. (1994). Severe radicular pathology in rats with longstanding diabetes. J. Neurol. Sci., 127, 29-35.
39. YAKSH, T.L. (1987). Spinal opiates: a review of their effect on spinal function with emphasis on pain processing. Acta Anaesthesiol. Scand. Suppl., 85, 25-37.
40. YAKSH, T.L., POGREL, J.W., LEE, Y.W. & CHAPLAN, S.R. (1995). Reversal of nerve ligation-mduced allodynia by spinal alpha-2 adrenoceptor agonists. J. Pharmacol. Exp. Ther., 272, 207-214.
41. YAKSH, T.L. & RUDY, T.A. (1976). Chronic catheterization of the spinal subarachnoid space. Physiol. Behav., 17, 1031-1036.
42. YAMAMOTO, T. & YAKSH, T.L. (1992). Comparison of the antinociceptive effects of pretreatment and posttreatment with intrathecal morphine and MK801, an NMDA antagonist, on the formalin test in the rat. Anesthesiology, 77, 757-763.